237 related articles for article (PubMed ID: 21600358)
1. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
Jordan WE; Emmons R; Vogl D; Morris GJ
Semin Oncol; 2011 Jun; 38(3):327-34. PubMed ID: 21600358
[No Abstract] [Full Text] [Related]
2. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
3. Prevention of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV
Clin Cancer Res; 2009 Sep; 15(18):5606-8. PubMed ID: 19737944
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of neuropathy with monoclonal gammopathy.
Latov N
Muscle Nerve; 2000 Feb; 23(2):150-2. PubMed ID: 10639604
[No Abstract] [Full Text] [Related]
6. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Golombick T; Diamond TH; Manoharan A; Ramakrishna R
Am J Hematol; 2012 May; 87(5):455-60. PubMed ID: 22473809
[TBL] [Abstract][Full Text] [Related]
9. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma precursor disease: current clinical dilemma and future opportunities.
Landgren O
Semin Hematol; 2011 Jan; 48(1):1-3. PubMed ID: 21232652
[No Abstract] [Full Text] [Related]
11. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Kristinsson SY; Björkholm M; Schulman S; Landgren O
Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
[TBL] [Abstract][Full Text] [Related]
12. Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome.
Vande Berg BC; Michaux L; Lecouvet FE; Labaisse M; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
Radiology; 1997 Jan; 202(1):247-51. PubMed ID: 8988218
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: current perspectives.
Slovak ML
Clin Lab Med; 2011 Dec; 31(4):699-724, x. PubMed ID: 22118745
[TBL] [Abstract][Full Text] [Related]
14. Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma.
Sathitruangsak C; Righolt CH; Klewes L; Tung Chang D; Kotb R; Mai S
Int J Cancer; 2017 Jan; 140(2):400-410. PubMed ID: 27711972
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
Brady K; Corash L; Bhargava V
Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
[TBL] [Abstract][Full Text] [Related]
16. Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.
Tomasson MH; Ali M; De Oliveira V; Xiao Q; Jethava Y; Zhan F; Fitzsimmons AM; Bates ML
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453544
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
18. [Management of monoclonal gammopathy].
Huijgens PC; Zweegman S
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1401-2. PubMed ID: 12174432
[TBL] [Abstract][Full Text] [Related]
19. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Horak P; Minarik J
Haematologica; 2005 Dec; 90(12):1713-4. PubMed ID: 16330455
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: clinical features and indications for therapy.
Dispenzieri A; Kyle RA
Best Pract Res Clin Haematol; 2005; 18(4):553-68. PubMed ID: 16026737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
